Alpha-1-acid glycoprotein is a prominent example of a molecule in which alterations in the structure of the surface oligosaccharides caused by anticancer drugs such as vemurafenib, a selective inhibitor of BRAF kinase, can be a great predictor in the diagnosis and determination of the effectiveness of treatments in patients with advanced melanoma harboring a BRAF mutation. This evidence concerns the gene BRAF and melanoma.